Jacobs Gary E. 4

4 · DermTech, Inc. · Filed Apr 21, 2021

Form 4

Period: 2021-04-19

Director10% Owner

Transactions

Exercise/Conversion
Common Stock
2021-04-19$1.08/sh+692$747→ 526,287 total
Exercise/Conversion
Common Stock
2021-04-19$1.08/sh+3,990$4,309→ 534,267 total
Exercise/Conversion
Stock Option (right to buy)
2021-04-19−13,171→ 0 total
Exercise: $1.12Exp: 2029-01-04→ Common Stock (13,171 underlying)
Exercise/Conversion
Common Stock
2021-04-19$1.12/sh+13,171$14,752→ 547,438 total
Exercise/Conversion
Stock Option (right to buy)
2021-04-19−3,990→ 0 total
Exercise: $1.08Exp: 2023-11-07→ Common Stock (3,990 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-04-19−3,990→ 0 total
Exercise: $1.08Exp: 2024-02-25→ Common Stock (3,990 underlying)
Exercise/Conversion
Common Stock
2021-04-19$1.08/sh+3,990$4,309→ 530,277 total
Exercise/Conversion
Stock Option (right to buy)
2021-04-19−692→ 0 total
Exercise: $1.08Exp: 2022-03-10→ Common Stock (692 underlying)

Holdings

Footnotes (3)

[F1]These shares of issuer common stock are directly held by Jacobs Investment Company LLC. Reporting person is the managing member of Jacobs Investment Company LLC. Reporting person exercises sole dispositive and sole voting power over the shares owned by Jacobs Investment Company LLC. Reporting person disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
[F2]These shares of issuer common stock may be deemed beneficially owned by the reporting person as Trustee of the Jacobs Family Trust Dated 11-9-99.
[F3]This option is fully vested and exercisable.

Documents

1 file